MaxCyte
MaxCyte STX®
MaxCyte-STXContact us for more information.
The MaxCyte STX® Scalable Transfection System uses Flow Electroporation™ Technology for rapid, high-performance engineering of cells for a broad array of applications. It addresses the R&D arena from early-stage development through pre-clinical work, including toxicology studies. Use the MaxCyte STX to improve the quality and time-to-market of your vaccines, small molecule drugs and biotherapeutics candidates.
High-Performance
- Cell viabilities >90% for commonly used cell types
- Transfection efficiencies >90%
- Computer-controlled system for day-to-day and user-to-user consistency
Flexible
- Engineer cell lines, primary cells and difficult-to-transfect cells
- Single animal component-free electroporation buffer for all cell types
- Pre-loaded library of validated, cell specific protocols for plug-and-play transfection
Scalable
- 5 x 106 to 7 x 108 cells in seconds
- Up to 2 x 1010 cells in <30 minutes
Quality
- Sterile, single use processing assemblies
- Closed, cGMP-compliant, ISO-certified and CE-marked instruments
- Supported by FDA master file
Scale up on the MaxCyte STX Requires No Re-optimization
